What is Endo-Systems?
Endo-Systems, a subsidiary of the LPG Group, operates at the intersection of medical aesthetics and wellness technology. The company specializes in endermologie®—a proprietary, non-invasive approach to cellulite treatment and body contouring. By providing high-performance hardware such as the Cellu M6 Alliance and Mobi M6, Endo-Systems empowers spas, medical practices, and wellness centers to deliver measurable, rapid body results. Their business model is fundamentally designed to foster financial growth for their professional partners by improving client retention rates and expanding the scope of available aesthetic services. Through its commitment to technological innovation, the company maintains a dominant footprint in the professional beauty equipment market.
How much funding has Endo-Systems raised?
Endo-Systems has raised a total of $68K across 1 funding round:
Debt
$68K
Debt (2021): $68K with participation from PPP
Key Investors in Endo-Systems
PPP
Public-Private Partnership
What's next for Endo-Systems?
Looking ahead, Endo-Systems is poised to leverage its recent capital influx to drive further innovation in its product pipeline and expand its international market presence. The strategic focus will likely center on scaling the adoption of its flagship technologies among high-end wellness facilities and medical aesthetic clinics. By optimizing its supply chain and enhancing its support ecosystem, the company aims to solidify its leadership in the non-invasive body contouring space. As the demand for effective, non-surgical aesthetic treatments continues to rise, Endo-Systems is strategically positioned to capture additional market share, ensuring long-term value creation for its stakeholders and partners.
See full Endo-Systems company page
